Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory

被引:0
作者
Angély Loubert
Antoine Regnault
Véronique Sébille
Jean-Benoit Hardouin
机构
[1] Modus Outcomes,
[2] a division of THREAD,undefined
[3] UMR INSERM 1246 – SPHERE,undefined
[4] University Hospital Platform of Methodology and Biostatistics,undefined
来源
BMC Medical Research Methodology | / 22卷
关键词
Clinical trials; Patient-reported outcomes; Rasch measurement theory; Calibration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 38 条
[11]  
Hutchinson M(2010)Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients-a simulation study BMC Med Res Methodol 10 1-260
[12]  
Anthoine E(2013)Power and sample size determination for the group comparison of patient-reported outcomes with rasch family models PLoS One 8 e57279-10
[13]  
Sébille V(2016)Differential item functioning (DIF) and subsequent bias in group comparisons using a composite measurement scale: A simulation study J Appl Meas 17 312-234
[14]  
Blanchin M(2019)Differential item functioning (DIF) in composite health measurement scale: recommendations for characterizing DIF with meaningful consequences within the Rasch model framework PLoS One 14 e0215073-15
[15]  
Rouquette A(1990)The effect of uncertainty of item parameter estimation on ability estimates Psychometrika 55 371-46
[16]  
Hardouin J-B(2013)Development and psychometric evaluation of the FACE-Q satisfaction with appearance scale: a new patient-reported outcome instrument for facial aesthetics patients Clin Plast Surg 40 249-144e
[17]  
Coste J(2005)Development and validation of a quality of life questionnaire for patients with colostomy or ileostomy Health Qual Life Outcomes 3 1-12
[18]  
Rouquette A(2006)Getting the measure of spasticity in multiple sclerosis: the multiple sclerosis spasticity scale (MSSS-88) Brain 129 224-556
[19]  
Tsutakawa RK(2016)Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (the PATH study): study protocol for a randomized controlled trial Trials 17 1-1490
[20]  
Johnson JC(2018)Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial Lancet Neurol 17 35-1358